Why the study?
Does indapamide retard improve blood pressure and metabolic parameters in patients with arterial hypertension and metabolic syndrome?
Does indapamide retard improve blood pressure and metabolic parameters in patients with arterial hypertension and metabolic syndrome?
Indapamide retard effectively lowers blood pressure and improves metabolic parameters in hypertensive patients with metabolic syndrome, overcoming traditional limitations of diuretic therapy in this population.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zhernakova et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: